It is important to note, however, that high throughput, high multiplex typing methods such as RAPD and particularly AFLP, will continue to be important complementary tools in Eucalyptus genetics for high density mapping [ 45] and high resolution positioning of disease resistance loci (e.g. [ 39]) to eventually allow map-based cloning efforts.
Nonetheless, the strength of intervention trials in establishing causality and the opportunity in observational studies to address long-term changes in health outcomes suggest that both approaches will continue to be useful and complementary in providing guidance regarding NNS use.
The World Fit for Children global agenda states that children should be exclusively breastfed for 6 months, and should continue to be breastfed with complementary feeding for up to 2 years of age.
Sargent concluded that both methods should continue to be used and explored in a complementary manner.
The analysis also suggests that the diversification strategy is unfortunately not prone to affect the income of the disfavored female-headed households in a significant way by itself and that complementary policies will continue to be needed to support this group, either in the form of direct transfers or boosting their participation in market activities.
Computational screening methods continue to be developed and improved as credible and complementary alternatives to high-throughput biochemical compound screening (HTS).
Thereafter, children should continue to be breastfed, while receiving appropriate and adequate complementary foods, for up to two years of age or beyond.
This is being continued and additional and complementary material, as discussed in previous sections of the document, is and will continue to be produced as the need is identified.
Its traditional use as an herbal remedy is documented in several handbooks of phytotherapy [ 2, 3] and continues to be popular in complementary medicine, especially Anthroposophical Medicine [ 4].
The Supreme Court's decision in Association for Molecular Pathology (AMP) v. Myriad Genetics invalidated patents on isolated gene sequences, but complementary DNA continues to be patentable subject matter.
